Status:
COMPLETED
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients
Lead Sponsor:
University Hospital Freiburg
Conditions:
Corneal Transplantation
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Most high risk keratoplasties are currently performed under systemic immunosuppression. Immunosuppressants are currently either Cyclosporine A or mycophenolate mofetile, administered for around 6 mont...
Eligibility Criteria
Inclusion
- high risk keratoplasty
Exclusion
- normal risk keratoplasty
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00409656
Start Date
December 1 2003
End Date
December 1 2005
Last Update
December 13 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.